Question

what are our national level duty at the age of this pandemic ( COVID-19)​

Answer 1

Answer:

See my answer and mark me as your brainlist..

Explanation:

The tragedy is that the government has enough and more foodgrains to feed people during this time; the real issue is of distribution—both in terms of broken supply chains, as well as the insistence of the government to limit distribution to beneficiaries under the National Food Security Act (NFSA), ie, priority ration card holders. This approach is flawed because the NFSA has many exclusions, with some of the poorest of the poor, nomadic or Adivasi communities, and the urban poor being left out. Moreover, ration cards are of no use to migrant workers stuck outside their home state.

There are similar issues of exclusion in other services as well, such as livelihoods and healthcare. This is where civil society must step in—to put pressure on the government to universalise these services.

We, at the Mazdoor Kisan Shakti Sangathan (MKSS) and through many networks, have been petitioning the government to distribute foodgrains to everyone, and we need to apply this kind of pressure at a larger scale. We’ve seen this work in the past, in the case of programmes such as NFSA (that focuses on food security) and the Mahatma Gandhi National Rural Employment Guarantee Act (NREGA)—both these were a result of consultative processes between the government and civil society. In fact, these rights-based legislations are providing us with the framework for public service delivery during this crisis, and they need to be effectively enhanced.

Answer 2

Answer:

releases and watch our regular press conferences.

Hydroxychloroquine arm of Solidarity Trial stops

17 June 2020

WHO announced that the hydroxychloroquine (HCQ) arm of the Solidarity Trial to find an effective COVID-19 treatment was being stopped.

The trial's Executive Group and principal investigators made the decision based on evidence from the Solidarity trial, UK's Recovery trial and a Cochrane review of other evidence on hydroxychloroquine.

Data from Solidarity (including the French Discovery trial data) and the recently announced results from the UK's Recovery trial both showed that hydroxychloroquine does not result in the reduction of mortality of hospitalised COVID-19 patients, when compared with standard of care.

Investigators will not randomize further patients to hydroxychloroquine in the Solidarity trial. Patients who have already started hydroxychloroquine but who have not yet finished their course in the trial may complete their course or stop at the discretion of the supervising physician.

This decision applies only to the conduct of the Solidarity trial and does not apply to the use or evaluation of hydroxychloroquine in pre or post-exposure prophylaxis in patients exposed to COVID-19......

i hope ur help ....